ARA-290 10MG
$63.00
ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue designed to model tissue protective signaling without erythropoietic activity. Researchers study ARA-290 in preclinical settings for its potential role in cytoprotection and inflammatory pathway modulation. Studies have also examined it in models involving neuropathic and metabolic stress responses.
In Stock
ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue developed to engage EPO related tissue protective pathways while avoiding red blood cell stimulating effects associated with full length erythropoietin. In research literature, ARA-290 is also referred to as cibinetide and is typically described as an 11 amino acid peptide modeled from the helix B surface region of erythropoietin.
Researchers study ARA-290 10MG in preclinical models for its potential role in cytoprotection, neuroinflammatory signaling, and small fiber neuropathy related endpoints. Studies have also examined ARA-290 in the context of metabolic stress, pain signaling, and immune cell mediated pathways, with interpretation depending on model design and exposure conditions.
- Specification: 10MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
MT1 10Mg 10MG refers to a 10-milligram format of MT1, a melanocortin research peptide commonly associated with melanotropin analog research. Researchers study MT1 in the context of melanocortin receptor signaling, pigmentation pathways, and related neuroendocrine models.
In Stock
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format pairing a CJC 1295 (no DAC) GHRH analogue with ipamorelin, a ghrelin receptor agonist peptide. This blend is commonly used in research that examines pulsatile growth hormone signaling pathways and IGF 1 related biomarkers. Studies have explored these peptides in endocrine and metabolism focused experimental models.
In Stock
Glutathione 1200MG is a 1200-milligram format of glutathione, a naturally occurring tripeptide composed of glutamate, cysteine, and glycine. Researchers study glutathione in redox biology and oxidative stress models, including pathways involved in cellular detoxification and antioxidant cycling.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 70MG is a 70-milligram combination format of three commonly studied research peptides: BPC-157, GHK-Cu, and TB-500. Researchers investigate these peptides in preclinical work involving connective tissue biology, angiogenesis signaling, and recovery related pathways. The blend is used in experimental designs where multiple peptide classes are evaluated together under controlled laboratory conditions.
In Stock
SNAP-8 – 10MG is a 10-milligram format of SNAP-8, a synthetic octapeptide commonly referred to as acetyl octapeptide 3. It is studied in cosmetic science as a topical model peptide related to SNAP-25 SNARE pathway research. Researchers have examined SNAP-8 in the context of peptide signalling and skin surface appearance studies.
In Stock
Lemon Bottle 3MG is a 3-milligram format of Lemon Bottle, a named research compound referenced in exploratory lab work where precise mass-based specification is required. Researchers may use materials labeled this way when screening physicochemical properties and analytical profiles across controlled experiments.
In Stock
BPC-157 + TB-500 – 10MG combines two widely discussed research peptides in a single 10 mg format. BPC-157 is a synthetic 15 amino acid peptide derived from a gastric protective protein fragment, while TB-500 refers to a thymosin beta 4 fragment commonly studied in peptide research. Researchers investigate this pairing in preclinical work involving connective tissue pathways, angiogenesis related signaling, and models of tissue repair and recovery.
In Stock
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
Trestolone Acetate (Ment) 50mg ml 10ml is a specified format of trestolone acetate, a synthetic 19 nor androgen and anabolic steroid ester. Researchers study MENT in endocrinology and androgen receptor focused models, including comparisons to testosterone derived compounds. Work has also examined trestolone in the context of gonadotropin regulation and progestogenic activity using preclinical and in vitro methods.
In Stock
CJC 1295 With DAC 5MG is a 5-milligram format of CJC-1295 with drug affinity complex (DAC), a synthetic growth hormone releasing hormone analogue peptide. Researchers study this modified GHRH fragment for its potential to extend peptide half life through albumin binding. Studies have examined CJC 1295 With DAC 5MG in preclinical and investigational settings focused on pulsatile GH signaling and IGF 1 related endpoints.
In Stock
